Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
van Cann T, Loyson T, Verbiest A, Clement PM, Bechter O, Willems L, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Debruyne PR, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B.
van Cann T, et al. Among authors: willems l.
Support Care Cancer. 2018 Mar;26(3):869-878. doi: 10.1007/s00520-017-3903-5. Epub 2017 Sep 30.
Support Care Cancer. 2018.
PMID: 28963584